Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepagina
  2. Aandelen
  3. Verenigd Koninkrijk
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. Nieuws
  7. Persberichten
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Rapport
Vertraagde tijd London Stock Exchange  -  17:35 01-12-2022
11200.00 GBX   +0.30%
30/11AstraZeneca stoot Amerikaanse vestiging af aan op technologie gerichte producent National Resilience
MT
29/11AstraZeneca verkoopt productiefaciliteit in Ohio aan National Resilience
MT
29/11AstraZeneca verkoopt vestiging in Ohio aan biotechbedrijf Resilience
MR
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Communiquťs de presse de la sociťtť ASTRAZENECA PLC
01/12Astrazeneca : Transparency Directive - Form 6-K
PU
01/12AstraZeneca showcases strength of hematology portfolio and pipeline across multiple har..
AQ
01/12University Of Oslo : Joining forces to help life science start-ups
AQ
30/11AstraZeneca showcases strength of haematology portfolio and pipeline across multiple h..
AQ
30/11Astrazeneca : showcases strength of haematology portfolio and pipeline across multiple har..
PU
30/11Astrazeneca snaps up Neogene for $320m in boost for cancer offering
AQ
30/11Astrazeneca : announces sale of its West Chester, Ohio (US) manufacturing site
PU
29/11AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell the..
AQ
29/11C4X shares fly after securing new licensing deal with Astrazeneca
AQ
28/11Exploring the Implementation of Complex In-Vitro Models for Drug Development
AQ
22/11AstraZeneca aims to redefine breast cancer care with new data across the treatment spe..
AQ
22/11AstraZeneca Aims to Redefine Breast Cancer Care With New Data Across the Treatment Spec..
BU
17/11Alexion AstraZeneca Rare Disease Completes Acquisition of LogicBio Therapeutics
AQ
16/11Alexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBioģ Therapeutics
BU
15/11AstraZeneca ranked in top three in the Access to Medicine Index
AQ
15/11AstraZeneca and Merck - LYNPARZA in Combination with Abiraterone and Prednisone or Pred..
AQ
15/11Innate pharma reports third quarter financial results
AQ
15/11Astrazeneca takes step forward in battle against cancer
AQ
14/11Enhertu recommended for approval in the EU by CHMP for patients with previously treated..
AQ
14/11Imfinzi plus chemotherapy recommended for approval in the EU by CHMP as first immunoth..
AQ
11/11IMFINZI and IMJUDO with chemotherapy approved in the US for patients with metastatic no..
BU
11/11Vanderbilt University : AstraZeneca lead scientist visits to discuss Vanderbilt collaborat..
AQ
11/11Imfinzi and Imjudo with chemotherapy approved in the US for patients with metastatic n..
AQ
11/11AstraZeneca expands global footprint in rare disease with availability of first Alexion..
AQ
11/11Astrazeneca boss urges UK to invest in medicines of the future
AQ
10/11AstraZeneca EVUSHELD Named on TIME's List of the Best Inventions of 2022
BU
10/11Astrazeneca : Q3 Earnings Snapshot
AQ
10/11AstraZeneca and partners act for equitable cancer care across Africa
AQ
10/11AstraZeneca and partners act for equitable cancer care across Africa ‘Acceleratin..
AQ
10/11Astrazeneca : Year-to-date and Q3 2022 results presentation
PU
10/11Astrazeneca : Year-to-date and Q3 2022 results announcement
PU
10/11Astrazeneca : Year-to-date and Q3 2022 results clinical trials appendix
PU
10/11Astrazeneca : Year-to-date and Q3 2022 results
PU
09/11PT027 Recommended by FDA Advisory Committee as New Rescue Treatment for Asthma
BU
09/11Beximco pharma warns on bangladesh covid revenues
AQ
07/11AstraZeneca presents data at ASN Kidney Week 2022 reinforcing urgent need for early scr..
AQ
04/11Astrazeneca : Beyfortus approved in the EU for the prevention of RSV lower respiratory tra..
PU
03/11AstraZeneca funds R&D Postdoctoral Challenge Finalists Six finalists awarded fully fund..
AQ
02/11Astrazeneca : funds R&D Postdoctoral Challenge finalists
PU
01/11Astrazeneca : Transparency Directive - Form 6-K
PU
01/11AstraZeneca advances scientific leadership in cardiovascular and renal diseases with ov..
AQ
01/11Vaxzevria receives full Marketing Authorisation in the EU for the prevention of COVID-1..
AQ
28/10Turning the tide on breast cancer in the Middle East and Africa (By Pelin Incesu)
AQ
28/10Turning the tide on breast cancer in the Middle East and Africa (By Pelin Incesu) There..
AQ
27/10ULTOMIRISģ (ravulizumab-cwvz) showed zero relapses in adults with neuromyelitis optica ..
BU
27/10Capivasertib plus Faslodex significantly improved progression-free survival vs. Faslode..
AQ
27/10Camizestrant significantly improved progression-free survival vs. Faslodex in SERENA-2..
AQ
27/10Investors bet on Astrazeneca's experimental breast cancer drug
AQ
26/10Camizestrant Significantly Improved Progression-free Survival Vs. FASLODEXģ (fulvestran..
BU
26/10Capivasertib plus FASLODEXģ (fulvestrant) significantly improved progression-free survi..
BU
26/10Astrazeneca's asthma drug fails to impress
AQ
25/10Update on the MESSINA Phase III trial for Fasenra in eosinophilic esophagitis
AQ
24/10IMJUDOģ (tremelimumab) in Combination With IMFINZIģ (durvalumab) Approved in the US for..
BU
24/10Imjudo (tremelimumab) in combination with Imfinzi approved in the US for patients with..
AQ
20/10AstraZeneca Announces Winners of Fourth Annual Cancer Community Awards
BU
20/10IDWeek data reinforces AstraZeneca's commitment to advance science in vaccines and immu..
AQ
18/10Qihan Biotech Appoints Tony W. Ho to its Board of Directors
AQ
18/10Ikena Oncology Provides Research & Development Update on IK-930 Program Targeting the H..
AQ
12/10HRSA ADR Panel Dismisses NACHC's 340B Complaint Against Two Drug Manufacturers
AQ
12/10Alexion aims to advance NMOSD treatment landscape with exceptional ULTOMIRISģ (ravulizu..
BU
11/10Girls Belong Here : AstraZeneca Shows Commitment to Gender Equality and Female Representat..
AQ
11/10Girls Belong Here : AstraZeneca Shows Commitment to Gender Equality and Female Representat..
AQ
11/10Japan's Shionogi to apply for COVID-19 vaccine approval by year-end
AQ
11/10Myocardial Infarction Pipeline Landscape Analysis of 50+ Companies by DelveInsight | Le..
AQ
10/10Jenny Sundqvist new CEO of InDex Pharmaceuticals
AQ
07/10Honeywell Begins Production of Near-Zero Global-Warming-Potential Medical Propellant; H..
AQ
06/10AstraZeneca builds on the fight against rare diseases
AQ
05/10The new Lupus Hub is now live
AQ
04/10Alexion, AstraZeneca Rare Disease to Acquire LogicBio Therapeutics to Accelerate Growth..
AQ
04/10Astrazeneca : Transparency Directive - Form 6-K
PU
03/10Southern District Of New York Dismisses Putative Class Action Against Pharmaceutical Co..
AQ
03/10Alexion, AstraZeneca Rare Disease to Acquire LogicBioģ Therapeutics to Accelerate Growt..
BU
30/09Astrazeneca : Remuneration Committee Chair Appointment - Form 6-K
PU
29/09Mayne pharma - appointment of chief executive officer and managing director
AQ
28/09Tezspire approved for a broad population of patients with severe asthma with no phenoty..
AQ
1  2  3  4  5  6  7  8  9  10Volgende
Volgende evenement op ASTRAZENECA PLC